who collaborating centre for influenza - australia
DESCRIPTION
WHO Collaborating Centre for Influenza - Australia. SENTINEL PRACTICE REPORTS. 40. 1997. 1994. 1996. 1995. 30. 2000. 1993. 1998. 1992. 1999. 20. Rate/1000 consultations. 10. 0. Laboratory Diagnosed Influenza - Australia 1992-2000. 1000. TYPE A. 800. TYPE B. 600. - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/1.jpg)
WHO Collaborating Centre for WHO Collaborating Centre for Influenza - AustraliaInfluenza - Australia
![Page 2: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/2.jpg)
Influenza in Australia 1992 - 2000Influenza in Australia 1992 - 2000
Laboratory Diagnosed Influenza - Australia 1992-2000
1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 10 1 4 7 1092 93 94 95 96 97 98 99 00
0
200
400
600
800
1000
Tota
l lab
orat
ory
diag
nose
s by
mon
th
TYPE A
TYPE B
0
10
20
30
40
Rat
e/10
00 c
onsu
ltatio
ns
1992
19941995 1996
1993
SENTINEL PRACTICE REPORTS
1997
1998
1999
2000
![Page 3: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/3.jpg)
Influenza in New ZealandInfluenza in New Zealand
1 5 9 13 17 21 25 29 33 37 41 45 49Week 2000
0
5
10
15
20
25
30
35
Viru
s is
olat
es
Flu A Flu B
18 22 26 30 34 380100200300400500600700
Rat
e pe
r 100
,000
19961997199819992000
![Page 4: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/4.jpg)
Monthly distribution of influenza isolatesThailand 2000
0
5
10
15
20
25
30
35
40
45
50
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
BA(H3N2)
A(H1N1)
A(untyped)
![Page 5: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/5.jpg)
Source of Virus Isolates Analysed Source of Virus Isolates Analysed Jan 2000 - Jan 2001Jan 2000 - Jan 2001
Australia
MalaysiaNew Caledonia
New Zealand
Philippines
Singapore
South Africa
Thailand
Taiwan
Vietnam
![Page 6: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/6.jpg)
Distribution of Types/SubtypesDistribution of Types/SubtypesJan 2000 - Jan 2001Jan 2000 - Jan 2001
A(H3N2)
A(H1N1)
B
13.8%59.5%
26.8%
41.1%
36.8% 22.2%
53.1%
26.2% 20.7%
46.3%
41.5%12.2%
Australia New Zealand
OtherAsia
![Page 7: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/7.jpg)
Influenza A(H1) Analysis Influenza A(H1) Analysis (1)(1)
ANTISERUMANTISERUMAA BB CC DD EE HumanHuman
Sera PoolSera PoolPassagePassageSampleSampleDateDate
REF. AgREF. Ag BAY/7BAY/7 JOH/82JOH/82 BEIJ/262BEIJ/262 SING/9SING/9 NC/20NC/20
AA A/BAYERN/7/95A/BAYERN/7/95 12801280 >2560>2560 2020 2020 2020 8080 X,E5X,E5BB A/JOH’BURG/82/96A/JOH’BURG/82/96 >2560>2560 >2560>2560 8080 8080 8080 320320 E4E4CC A/BEIJING/262/95A/BEIJING/262/95 2020 4040 640640 640640 320320 8080 E5E5DD A/SINGAPORE/9/98A/SINGAPORE/9/98 <20<20 <20<20 8080 8080 8080 4040 X,MD4X,MD4EE A/NEW CALEDONIA/20/99A/NEW CALEDONIA/20/99 <20<20 <20<20 4040 4040 160160 2020 E5E5
TEST AgTEST AgA/JOH’BURG/31/2000A/JOH’BURG/31/2000 <20<20 <20<20 8080 8080 640640 4040 XE2XE2B/VICTORIA/526/2000B/VICTORIA/526/2000 2020 2020 320320 320320 12801280 8080 MD2MD2 15.09.0015.09.00A/C’CHURCH/95/2000A/C’CHURCH/95/2000 2020 4040 160160 160160 320320 8080 MD3MD3 22.10.0022.10.00A/STH AUST/78/2000A/STH AUST/78/2000 2020 8080 320320 320320 640640 8080 MD2MD2 16.09.0016.09.00A/WELLINGTON/8/2000A/WELLINGTON/8/2000 4040 4040 320320 640640 12801280 160160 MDX,MD1MDX,MD1A/AUCKLAND/100/2000A/AUCKLAND/100/2000 4040 4040 320320 640640 12801280 160160 MD3MD3 29.08.0029.08.00A/STH AUST/157/2000A/STH AUST/157/2000 2020 4040 320320 320320 12801280 8080 MD2MD2 23.10.0023.10.00A/PERTH/256/2000A/PERTH/256/2000 2020 2020 160160 320320 640640 8080 MD2MD2 21.09.0021.09.00A/PERTH/266/2000A/PERTH/266/2000 2020 2020 320320 320320 640640 8080 MD2MD2 25.09.0025.09.00
![Page 8: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/8.jpg)
Influenza A(H1) Analysis Influenza A(H1) Analysis (2)(2)
ANTISERUMANTISERUM
HumanHumanSera PoolSera Pool
PassagePassage SampleSampleDateDate
AA BB CC DD EE FF
REF. AgREF. Ag BAY/7BAY/7 JOH/82JOH/82 BEIJ/262BEIJ/262 SING/9SING/9 NC/20NC/20 FUJ/156FUJ/156
AAA/BAYERN/7/95A/BAYERN/7/95 12801280 >2560>2560 2020 2020 <20<20 <20<20 160160 X,E5X,E5BBA/JOH’BURG/82/96A/JOH’BURG/82/96 >2560>2560 >2560>2560 8080 4040 8080 2020 320320 E5E5CCA/BEIJING/262/95A/BEIJING/262/95 2020 8080 12801280 12801280 640640 320320 8080 E5E5DDA/SINGAPORE/9/98A/SINGAPORE/9/98 <20<20 <20<20 160160 160160 160160 160160 4040 X,MD4X,MD4EE A/NEW CAL/20/99A/NEW CAL/20/99 <20<20 <20<20 8080 640640 320320 640640 2020 E5E5FF A/FUJIAN/156/2000A/FUJIAN/156/2000 <20<20 2020 8080 160160 640640 12801280 4040 E2,E2,E1E2,E2,E1
TEST AgTEST AgA/PERTH/46/2000A/PERTH/46/2000 8080 8080 640640 12801280 >2560>2560 >2560>2560 160160 X,MD1X,MD1 16.10.0016.10.00A/BANGKOK/335/2000A/BANGKOK/335/2000 <20<20 <20<20 160160 160160 640640 12801280 8080 E3,MD1E3,MD1 29.08.0029.08.00A/H.K./1841/2000A/H.K./1841/2000 2020 2020 160160 160160 320320 320320 8080 C2,C2,MD1C2,C2,MD1A/TEXAS/87/2000A/TEXAS/87/2000 <20<20 2020 160160 160160 640640 640640 8080 M1,C2,MD1M1,C2,MD1A/TEXAS/90/2000A/TEXAS/90/2000 640640 >2560>2560 2020 2020 2020 2020 160160 M1,C2,MD1M1,C2,MD1A/WUHAN/292/2000A/WUHAN/292/2000 2020 8080 320320 320320 12801280 >2560>2560 160160 E2,E2,E1E2,E2,E1A/H.K./1924/2000A/H.K./1924/2000 <20<20 <20<20 160160 160160 640640 640640 8080 C2,C2,MD1C2,C2,MD1A/ENG/192/2000A/ENG/192/2000 8080 320320 8080 4040 160160 4040 160160 C2,E1,E3C2,E1,E3A/SING/37/2000A/SING/37/2000 <20<20 2020 160160 160160 640640 12801280 8080 MD3MD3 09.06.0009.06.00A/SING/44/2000A/SING/44/2000 <20<20 <20<20 8080 8080 320320 640640 8080 MD2MD2 24.10.0024.10.00A/PERTH/16/2000A/PERTH/16/2000 4040 8080 640640 640640 12801280 >2560>2560 160160 X,MD1X,MD1 04.09.0004.09.00A/PERTH/17/2000A/PERTH/17/2000 4040 4040 320320 640640 >2560>2560 >2560>2560 8080 X,MD1X,MD1 07.09.0007.09.00
![Page 9: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/9.jpg)
Antigenic Analysis of A(H1N1) Antigenic Analysis of A(H1N1) IsolatesIsolates
A/Bayern14.4%
A/New Caledonia85.6%
A/Bayern4.2%
A/New Caledonia95.8%
Jan - Aug 2000 Sept 2000 - Jan 2001
![Page 10: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/10.jpg)
0
8.4
2468
Brazil/231/00nimr [2/00]Sth Dakota/4/00cdc [12/00]Dakar/5/00nimr [7/00]Buenos Aries/R73/00nimr [6/00]
Neuquen/R79/00nimr [7/00]Bratislava/23/00nimr [12/00]Buenos Aries/R73/00nimr [7/00]
Texas/70/00cdc [11/00]Asuncion/1041/00nim r [10/00]
Dakar/13/00nimr [8/00]Berlin/127/00nimr [11/00]
Bratislava/28/00nimr [12/00]Dakar/17/00nimr [8/00]Iowa/4/00cdc [12/00]
Bangkok/34/00 [1/00]Auckland/3/00 [5/00]Mauritius/601/00nimr [5/00]
Bangkok/45/00 [1/00]Bangkok/196/00 [3/00]
Bangkok/2/00 [1/00]Johannesburg/14/00 [5/00]
Florida/8/00cdc [10/00]Singapore/5/00 [3/00]Guangdong/273/00cdc [8/00]Hong Kong/1799/00nimr [9/00]
Wuhan/292/00niid [9/00]Okinawa/159/00niidChristcurch/5/00 [6/00]Hong Kong/1379/00nimr [5/00]
Fujian/156/00cdc [8/00]Singapore/4/00 [3/00]
Henan/91/00cdc [9/00]Hong Kong/1924/00nimr [10/00]
Nagassaki/16/00niidSingapore/3/00 [3/00]Tennessee/5/00cdc [11/00]
Taiwan/8/00 [1/00]Finland/768/00nimr [11/00]
New Caledonia/20/99New Caledonia/13/00
Singapore/44/00 [10/00]Singapore/31/00 [5/00]
Miyagi/3/00New Caledonia/11/00
Beijing/262/95Hanoi/21/99
Taiwan/1/86Texas/36/91
Bayern/7/95Johannesburg/82/96
Sth Australia/8/00 [7/00]Sth Australia/27/00 [7/00]
Yokohama/24/00Yokohama/60/00
Chiba/389/00Florida/9/00cdc
Chile/4795/00cdc
GLU 120 GLXLYS 162 MET
VAL 165 ALA
ASP 186 ASN
Influenza A(H1N1) IsolatesHA1 Sequence Analysis
![Page 11: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/11.jpg)
0
4.1
24
New Caledonia/18/88New Caledonia/11/00Miyagi/3/00
Johannesburg/13/00 [5/00]Bangkok/45/00 [1/00]Bangkok/195/00 [4/00]
Bangkok/34/00 [1/00]New Caledonia/20/99
Peru/1261/99cdcPeru/1798/99cdc
California/26/99cdcBeijing/262/95
Wuhan/371/95Yokohama/24/00
South Australia/8/00[7/00]South Australia/21/00 [7/00]
Johannesburg/82/96Texas/36/91
Influenza A(H1N1) IsolatesNA Sequence Analysis
![Page 12: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/12.jpg)
Influenza A(H3) AnalysisInfluenza A(H3) Analysis
ANTISERUMANTISERUMAA BB CC DD EE FF HumanHuman
Sera PoolSera PoolPassagePassage SampleSample
DateDateREF. AgREF. Ag SYD/5SYD/5 MOS/10MOS/10 PAN/2007PAN/2007 TEHRANTEHRAN SYD/203SYD/203 ULANULAN
AA A/SYDNEY/5/97A/SYDNEY/5/97 640640 640640 640640 640640 12801280 640640 8080 CEK2,E5CEK2,E5BB A/MOSCOW/10/99A/MOSCOW/10/99 320320 >2560>2560 640640 640640 12801280 12801280 160160 E7E7CC A/PANAMA/2007/99A/PANAMA/2007/99 8080 4040 640640 160160 160160 640640 4040 E7E7DD A/TEHRAN/14/99A/TEHRAN/14/99 160160 640640 640640 12801280 12801280 12801280 8080 X2,E3X2,E3EE A/SYDNEY/203/2000A/SYDNEY/203/2000 640640 12801280 640640 640640 >2560>2560 12801280 8080 E4E4FF A/ULAN/UDE/01/2000A/ULAN/UDE/01/2000 320320 8080 320320 640640 320320 12801280 8080 E6E6
TEST AgTEST AgA/VICTORIA/346/2000A/VICTORIA/346/2000 320320 12801280 640640 640640 640640 640640 160160 X,MD1X,MD1A/WELLINGTON/13/2000A/WELLINGTON/13/2000 8080 320320 320320 320320 320320 320320 4040 MDX,MD1MDX,MD1A/WAIKATO/7/2000A/WAIKATO/7/2000 640640 12801280 640640 12801280 12801280 12801280 8080 MDX,MD1MDX,MD1A/WAIKATO/10/2000A/WAIKATO/10/2000 320320 12801280 12801280 12801280 >2560>2560 12801280 160160 MEKX,MD1MEKX,MD1A/WAIKATO/14/2000A/WAIKATO/14/2000 640640 12801280 12801280 12801280 >2560>2560 >2560>2560 320320 MDX,MD1MDX,MD1A/WAIKATO/15/2000A/WAIKATO/15/2000 320320 640640 640640 640640 640640 640640 8080 MEKX,MD1MEKX,MD1A/WAIKATO/17/2000A/WAIKATO/17/2000 4040 160160 8080 160160 8080 8080 <20<20 MEKX,MD1MEKX,MD1A/STH AUST/101/2000A/STH AUST/101/2000 4040 160160 160160 160160 160160 160160 2020 MDX,MD1MDX,MD1 28.09.0028.09.00A/STH AUST/136/2000A/STH AUST/136/2000 160160 640640 640640 12801280 12801280 320320 4040 MDX,MD1MDX,MD1 11.10.0011.10.00A/BRISBANE/71/2000A/BRISBANE/71/2000 8080 160160 160160 160160 160160 160160 <20<20 MDX,MD1MDX,MD1 20.09.0020.09.00A/BRISBANE/72/2000A/BRISBANE/72/2000 8080 640640 640640 640640 12801280 320320 4040 MDX,MD1MDX,MD1 23.09.0023.09.00A/BRISBANE/75/2000A/BRISBANE/75/2000 8080 160160 160160 320320 320320 320320 2020 MDX,MD1MDX,MD1 03.10.0003.10.00
![Page 13: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/13.jpg)
Antigenic Analysis of A(H3N2) Antigenic Analysis of A(H3N2) IsolatesIsolates
A/Sydney5.9%
A/Sydney (low)12.3%
A/Moscow67.8%
A/Moscow (low)14.0%
A/Moscow62.5%
A/Moscow (low)37.5%
Jan - Aug 2000 Sept 2000 - Jan 2001
![Page 14: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/14.jpg)
HA H3N2
0
10.5
246810
Christchurch/85/00 [9/00]Victoria/557/00 [9/00]
Sth Australia/71/00 [8/00]Victoria/564/00 [10/00]
Sydney/274/00 [9/00]Perth/243/00 [9/00]
California/9/00 [10/00]Sth Australia/87/00 [9/00]Townsville/7/00 [9/00]Sydney/217/00 [8/00]Hong Kong/1923/00nimrDarwin/10/00 [10/00]Brisbane/71/00 [9/00]
Christchurch/39/00 [8/00]Perth/10/00 [8/00]
Fujian/140/00cdc [7/00]Sydney/213/00 [8/00]
Victoria/570/00 [11/00]Guangzhou/483/00niid
Sydney/221/00 [8/00]Guandong/233/00cdc [6/00]
Hong Kong/28278/00nimr [9/00]Sydney/203/00 [5/00]
A/Panama/2007/99Argentina/5995/00cdc [10/00]
CRica/2/00cdc [7/00]Singapore/2/00 [3/00]Johannesburg/50/00saBrisbane/37/00 [9/00]
Christchurch/80/00 [9/00]Ulan Ude/01/00Victoria/509/00 [7/00]
A/Tehran/14/99Taiwan/3/00 [1/00]Perth/1/00 [3/00]
Wellington/58/00 [9/00]Brisbane/7/00 [6/00]
Townsville/4/00 [8/00]New Caledonia/7/00 [7/00]
Victoria/555/00 [9/00]Christchurch/94/00 [10/00]
India/3783/00cdc [7/00]Singapore/63/00 [11/00]Darwin/1/00 [5/00]
A/Moscow/10/99Bangkok/62/00 [2/00]
A/Sydney/5/97A/Sth Africa/1147/96
A/Wuhan/359/95A/Johannesburg/33/94
Guangdong/183/00niidA/Nanchang/933/95
ARG 50 GLYSER 199 PROSER 247 CYSPRO 273 SER
GLY 5 VALGLU 33 HISLYS 92 THRASN 144 ILEASP 271 ASN
Influenza A(H3N2) IsolatesHA1 Sequence Analysis
![Page 15: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/15.jpg)
0
4.0
2
Tehran/14/99Brisbane/32/00 [9/00]
Bangkok/62/00 [2/00]Darwin/6/00 [10/00]
Townsville/7/00 [9/00]Victoria/564/00 [10/00]
Malaysia/41/99Christchurch/3/00
Ulan Ude/1/00Perth/213/00 [2/00]Sydney/201/00 [2/00]Darwin/1/00 [5/00]
Victoria/572/99Sydney/203/00 [5/00]
Victoria/1/99Perth/1/00 [3/00]
Victoria/522/99Moscow/10/99
Sth Australia/1/00 [1/00]Bangkok/140/00 [3/00]
Ulan Ude/2/99cdcShanghai/42/99cdc
Brisbane/65/99Hong Kong/4867/98cdcPanama/2007/99
Alaska/22/99cdcChile/5049/99cdc
Malaysia/5/99Sichuan/346/98
Connecticut/5/99cdcSydney/5/97
Wuhan/359/95Nanchang/933/95
Johannesburg/32/94
Influenza A(H3N2) IsolatesNA Sequence Analysis
![Page 16: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/16.jpg)
Influenza B Analysis (1)Influenza B Analysis (1)ANTISERUMANTISERUM
AA BB CC DD EE FF GG
BEIJ/184BEIJ/184 YAM/166YAM/166 SHEN/654SHEN/654 SICH/379SICH/379 B/JOH/5B/JOH/5 AUCK/1AUCK/1 JOH/45JOH/45 PASSAGEPASSAGE SAMPLESAMPLE DATEDATEREF. AgREF. Ag
AA B/BEIJING/184/93B/BEIJING/184/93 320320 320320 2020 12801280 320320 320320 640640 E10E10
BB B/YAMANASH/166/98B/YAMANASH/166/98 320320 640640 4040 >2560>2560 640640 640640 640640 E10E10
CC B/SHENZHEN/654/99B/SHENZHEN/654/99 4040 4040 320320 160160 160160 160160 160160 E8E8
DD B/SICHUAN/379/99B/SICHUAN/379/99 160160 160160 2020 640640 160160 160160 160160 E11E11
EE B/JOHANNESBURG/5/99B/JOHANNESBURG/5/99 160160 160160 2020 12801280 320320 160160 640640 E5E5
FF B/AUCKLAND/1/2000B/AUCKLAND/1/2000 320320 160160 <20<20 320320 160160 320320 320320 CEK1E4CEK1E4
GG B/JOHANNESBURG/45/99B/JOHANNESBURG/45/99 160160 160160 2020 640640 160160 160160 320320 E8E8
TEST AgTEST Ag
B/VICTORIA/525/2000B/VICTORIA/525/2000 160160 4040 160160 320320 320320 160160 320320 MD2MD2 13.09.0013.09.00
B/CHRISTCHURCH/9/2000B/CHRISTCHURCH/9/2000 8080 2020 160160 320320 160160 160160 160160 MD3MD3 30.08.0030.08.00
B/CHRISTCHURCH/7/2000B/CHRISTCHURCH/7/2000 160160 4040 160160 640640 640640 320320 640640 MD2MD2 16.08.0016.08.00
B/VICTORIA/733/2000B/VICTORIA/733/2000 160160 2020 160160 160160 320320 160160 160160 MD2MD2 22.08.0022.08.00
B/VICTORIA/741/2000B/VICTORIA/741/2000 8080 4040 160160 320320 320320 160160 320320 MD2MD2 05.09.0005.09.00
B/VICTORIA/1/2000B/VICTORIA/1/2000 160160 4040 160160 640640 640640 640640 640640 MD1MD1
B/SHANGHAI/72/99B/SHANGHAI/72/99 160160 160160 2020 640640 320320 160160 320320 E5E5
B/MEXICO/84/2000B/MEXICO/84/2000 160160 8080 4040 640640 320320 160160 320320 E5E5
B/MADAGASCAR/50212/99B/MADAGASCAR/50212/99 8080 160160 2020 640640 160160 8080 320320 E6E6
![Page 17: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/17.jpg)
Influenza B Analysis (2)Influenza B Analysis (2)
ANTISERUMANTISERUM
PASSAGEPASSAGEAA BB CC DD EE
BEIJ/184BEIJ/184 YAM/166YAM/166 SICH/379SICH/379 B/JOH/5B/JOH/5 VIC/504VIC/504REF. AgREF. Ag
AAB/BEIJING/184/93B/BEIJING/184/93 320320 320320 640640 640640 320320 E10E10BBB/YAMANASH/166/98B/YAMANASH/166/98 320320 320320 12801280 320320 160160 E11E11CCB/SICHUAN/379/99B/SICHUAN/379/99 160160 160160 640640 320320 320320 E9E9DDB/JOHANNESBURG/5/99B/JOHANNESBURG/5/99 320320 320320 12801280 320320 320320 E5E5EEB/VICTORIA/504/2000B/VICTORIA/504/2000 8080 <20<20 160160 160160 320320 CEK1E1CEK1E1
TEST AgTEST AgB/C’CHURCH/22/2000B/C’CHURCH/22/2000 160160 4040 640640 320320 640640 MD3MD3 02.10.0002.10.00B/VICTORIA/114/2000B/VICTORIA/114/2000 160160 8080 640640 320320 640640 MDX,MD1MDX,MD1 26.09.0026.09.00B/VICTORIA/107/2000B/VICTORIA/107/2000 160160 2020 320320 160160 320320 MKX,MD1MKX,MD1 16.08.0016.08.00B/WELLINGTON/21/2000B/WELLINGTON/21/2000 160160 4040 640640 320320 640640 MD2MD2 27.09.0027.09.00B/BRISBANE/30/2000B/BRISBANE/30/2000 160160 4040 640640 320320 640640 MDX,MD1MDX,MD1 19.09.0019.09.00B/BRISBANE/38/2000B/BRISBANE/38/2000 320320 8080 640640 320320 320320 MDX,MD1MDX,MD1 25.09.0025.09.00B/STH AUST/85/2000B/STH AUST/85/2000 8080 <20<20 160160 160160 320320 MDX,MD1MDX,MD1 07.09.0007.09.00B/STH AUST/86/2000B/STH AUST/86/2000 8080 2020 320320 160160 320320 MDX,MD1MDX,MD1 07.09.0007.09.00B/VICTORIA/321/2000B/VICTORIA/321/2000 8080 <20<20 320320 160160 640640 X,MD1X,MD1 12.09.0012.09.00
SAMPLESAMPLE DATEDATE
![Page 18: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/18.jpg)
B/Shangdong6.7%
B/Beijing90.5%
B/Sichuan2.9%
B/Beijing60.3%
B/Sichuan39.7%
Antigenic Analysis of Type B Antigenic Analysis of Type B IsolatesIsolates
Jan - Aug 2000 Sept 2000 - Jan 2001
![Page 19: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/19.jpg)
0246
ALA 28 VALARG 69 SERALA 127 ILELYS 149 ARG
7.9
Brisbane/4/00 [8/00]Sth Australia/24/00 [7/00]
Victoria/541/00 [10/00]California/6/00cdc [11/00]
Canada/16188/00cdc [11/00]Washington/3/00cdc [12/00 ]
Victoria/520/00 [9/00]Victoria/529/00 [9/00]
New York/2/00cdc [12/00]Sth Australia/47/00 [8/00]Hong Kong/548/00nimr [9/00]
Sydney/217/00 [8/00]Hong Kong/564/00nimr [10/00]
Johannesburg/5/99Moscow/4/00nimr [4/00]
Buenos Aries/R64/00nimr [6/00]Hong Kong/533/00nimr [6/00]Victoria/502/00 [7/00]
Shizuoka/480/00niidVictoria/504/00 [8/00]
Sichuan/379/99Washington/2/00cdc [9/00]
Sth Australia/5/99Christchurch/5/00 [7/00]
Lisbon/3/00nimr [10/00]Alaska/16/00cdc [11/00]
Sendai/H518/00cdcSydney/201/00 [7/00]
Gaungdong/120/00cdc [3/00]Perth/2/00 [5/00]Victoria/527/00 [9/00]
Brazil/975/00cdcAuckland/3/00 [6/00]
Perth/1/00 [2/00]Bangkok/29/00 [ 1/00]Singapore/25/00 [8/00]
Osako/C-1/00Victoria/503/00 [8/00]Argentina/113/00cdc [ 8/00]
Yamanshi/166/98Hong Kong/557/00cdc [10/00]
Taiwan/2/00 [3/00]Shenzhen/654/99
Philippines/289/00 [5/00]Hong Kong/588/00cdc [10/00]
Beijing/184/93Harbin/7/94
Beijing/243/97Shangdong/7/97
LYS 58 PHEASN 126 ASP
ASN 196 ASPASP 232 GLU
ILE 87 VALLYS 88 ARG
Influenza B IsolatesHA1 Sequence Analysis
![Page 20: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/20.jpg)
0
3.7
2
Shanghai/75/99cdcShanghai/72/99
Sichuan/379/99Christchurch/2/00[7/00]
Perth/2/00 [5/00]Victoria/311/00 [8/00]/Victoria/527/00 [9/00]
Johannesburg/5/99Sth Australia/5/99
Bucharest/311/98cdcVictoria/504/00 [8/00]
Perth/1/00 [2/00]Auckland/1/00 [5/00]
Bangkok/11/00 [1/00]Yamanashi/166/98
Harbin/7/97Beijing/184/93
Panama/45/90Bangkok/34/99
Sichuan/40/99cdcShangdong/7/97Beijing/243/97
Bangkok/54/99cdc/Victoria/2/87
Influenza B IsolatesNA Sequence Analysis
![Page 21: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/21.jpg)
New Cal/20/99
Auck/32/2000
Joh/82/96
Texas/87/2000
Wuhan/292/2000
USA GMT USA >40 Aust GMT Aust >400
100
200
300
400
Influenza Type A(H1N1) VaccineResponses - Older Adults 2000
![Page 22: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/22.jpg)
Influenza Type A(H3N2) VaccineInfluenza Type A(H3N2) VaccineResponses - Older Adults 2000Responses - Older Adults 2000
USA GMT USA >40 Aust GMT Aust >400
20
40
60
80
100
120
140
160
Sydney/5/97
Panama/2007/99
Tehran/14/99
Sydney/203/2000
Ulan Ude/1/2000
VBrazil/991/2000
Fujian/40/2000
Hong Kong/1923/2000
Lyon/1242/2000
![Page 23: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/23.jpg)
Influenza Type B VaccineInfluenza Type B VaccineResponses - Older Adults 2000Responses - Older Adults 2000
Yamanashi/166/98Joh/5/99Sichuan/379/99Auckland/1/2000Christchurch/2/2000Zagreb/3578/99Victoria/504/2000Alaska/16/2000Series 9
USA GMT USA >40 Aust GMT Aust >400
20
40
60
80
100
120
![Page 24: WHO Collaborating Centre for Influenza - Australia](https://reader035.vdocuments.net/reader035/viewer/2022062810/56815d36550346895dcb35ac/html5/thumbnails/24.jpg)